Project specialising in antibody screening
Adaptyv Biosystems has raised €37M across 3 funding rounds from 15 investors, most recently a Series A round in Aug 2026. Based in Switzerland; active in Healthtech. Data as of 21 Sept 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-08-26 | Series A | €34M | ACE Ventures,ByFounders,Highland Europe,Y Combinator | View deal → |
| 2022-02-14 | Pre-Seed | €2.4M | Acequia Capital,Axial,FAST,Founders,Hawktail VC,Rheingau Founders+5 more | View deal → |
| 2021-08-06 | Grant | €93k | EPFL Tech Launchpad | View deal → |
